Cidea Modulators In The Treatment Of Acne, Of Seborrhoeic Dermatitis Or Of Hyperseborrhoea

Abstract

The invention relates to an in vitro or in vivo method for screening for candidate compounds for the preventive or curative treatment of acne, of seborrhoeic dermatitis or of skin disorders associated with hyperseborrhoea, comprising the determination of the ability of a compound to modulate the expression or the activity of the CIDEA protein, and also to the use of modulators of the expression or of the activity of this protein, for the treatment of acne, of seborrhoeic dermatitis or of skin disorders associated with hyperseborrhoea. The invention also relates to methods for the in vitro diagnosis of or in vitro prognosis for these pathologies.


Claims
Download PDF
Document Preview
Document History
  • Publication: Nov 12, 2009
  • Application: May 7, 2009
    WO EP 2009055551 W
  • Priority: Nov 13, 2008
    FR FR 0857692 A
  • Priority: May 7, 2008
    US US 7161208 P

Download Citation


Sign in to the Lens

Feedback